The pharmaceutical and nutraceutical industries, which have been expanding for several years, have experienced a real boom during the pandemic. In order to be competitive and meet new market demands, many companies needed to readjust their production cycles, trying to optimise time, costs and resources as much as possible. In Europe, in particular, the counting sector has grown, a sector…
Packaging strongly influences purchasing choices, even in the pharmaceutical industry. The new consumer classes are much more sensitive to environmental issues and, consequently, more inclined to buy products packaged with recyclable materials. Pharmaceutical packaging, as shown by some recent studies, is one of the industries that is focusing more on green, both from a strategic and a social responsibility point…
Sustainability and innovation have always been two constants in Tecnomaco's production process. Our machines are designed to increase the efficiency of companies operating in the pharmaceutical and nutraceutical sectors, while at the same time guaranteeing sustainable production, capable of reducing energy and resource consumption, reducing costs and processing times, improving production processes and making life easier for employees. In addition…
Tecnomaco’s mission has always been to design effective, innovative and customisable solutions. We do this through a very simple strategy, which combines technical expertise with total attention to the customer. Thanks to this approach, our products have continued to travel all over the world, even during the pandemic. In an interview with Tommaso Serafini, Tecnomaco sales area manager, we talk…
The previous Tecnomaco brand was already the result of an initial restyling operation, in which the use of squares making up the T was replaced by the harmony of rounds, with a consequent change of font. But after so many years we opted for a radical change, redefining the visual identity of our company, to communicate new intentions and to…
According to estimates provided by data science company IQVIA, by 2022 global expenditure on pharmaceuticals will have risen to 1,430 billion, compared to 658 billion spent in 2006. Several factors are influencing this: urbanisation processes and a wider spread of chronic diseases, an ageing population and greater attention to health. Growing consumer demand has led to the emergence of new…
